EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY

被引:0
|
作者
Saliba, Faouzi [1 ]
De Simone, Paolo [2 ]
Nevens, Frederik [3 ]
De Carlis, Luciano [4 ]
Metselaar, Herold [5 ]
Beckebaum, Susanne [6 ]
Jonas, Sven [7 ]
Sudan, Debra [8 ]
Fischer, Lutz [9 ]
Fung, John J. [10 ]
Jiang, Hai [11 ]
Junge, Guido [12 ]
机构
[1] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
[2] Azienda Osped Univ Pisana, Pisa, Italy
[3] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[4] Osped Niguarda Ca Granda, Milan, Italy
[5] Univ Hosp Rotterdam, Erasmus MC, Rotterdam, Netherlands
[6] Univ Hosp Essen, Essen, Germany
[7] Univ Med Ctr Leipzig, Leipzig, Germany
[8] Duke Univ, Med Ctr, Durham, NC USA
[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1430A / 1431A
页数:2
相关论文
共 50 条
  • [1] EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nevens, F.
    De Carlis, L.
    Metselaar, H.
    Saliba, F.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Fung, J.
    Jiang, H.
    Junge, G.
    De Simone, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S551 - S552
  • [2] Efficacy and Safety of Everolimus with Early Reduction or Elimination of Tacrolimus in 719 de Novo Liver Transplant Recipients - Results at 12 Months
    De Simone, P.
    Nevens, F.
    Duvoux, C.
    Koneru, B.
    McCormack, L.
    McCaughan, G.
    Navasa, M.
    Dong, G.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    TRANSPLANTATION, 2012, 94 (10) : 220 - 220
  • [3] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 12 MONTHS
    Saliba, Faouzi
    Duvoux, Christophe
    Durand, Francois
    Neau-Cransac, Martine
    Hardwigsen, Jean
    Pageaux, Georges
    Boleslawski, Emmanuel
    TRANSPLANT INTERNATIONAL, 2012, 25 : 39 - 39
  • [4] Everolimus with Early Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients-12 Month Efficacy and Safety Results from H2304 Study
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 28 - 28
  • [5] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
    Duvoux, C.
    Saliba, F.
    Durand, F.
    Neau-Cransac, N.
    Hardwigsen, J.
    Pageaux, G.
    Boleslawski, E.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
  • [6] Efficacy and Safety of Everolimus in De Novo Liver Transplant Recipients-12 Month Results of a Randomized, Multicenter Study.
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    LIVER TRANSPLANTATION, 2012, 18 : S109 - S110
  • [7] Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 238 - 238
  • [8] Impact of Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus on the Evolution of Renal Function in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
    Metselaar, H. J.
    Saliba, F.
    Schemmer, P.
    Foltys, D.
    Fabregat, J.
    Ericzon, B. -G.
    Dong, G.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    TRANSPLANTATION, 2012, 94 (10) : 44 - 44
  • [9] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    TRANSPLANTATION, 2014, 98 : 80 - 80
  • [10] Efficacy and Safety of Everolimus With Low-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Randomized Study
    Qazi, Y.
    Shaffer, D.
    Kaplan, B.
    Kim, D.
    Luan, F.
    Peddi, V.
    Shihab, F.
    Tomlanovich, S.
    Yilmaz, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 80 - 80